{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:11:28Z","timestamp":1781089888552,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1002\/jps.24104","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T22:06:45Z","timestamp":1407190005000},"page":"3176-3182","source":"Crossref","is-referenced-by-count":22,"title":["Solubility and Some Crystallization Properties of Conglomerate Forming Chiral Drug Guaifenesin in Water"],"prefix":"10.1016","volume":"103","author":[{"given":"Robert R.","family":"Fayzullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemfira A.","family":"Bredikhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Bredikhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Seidel-Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24104_bb0010","series-title":"Chirality and biological activity of drugs","author":"Crossley","year":"1995"},{"key":"10.1002\/jps.24104_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/js9703683","article-title":"The impact of stereoisomerism in bioequivalence studies","volume":"87","author":"Midha","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24104_bb0020","series-title":"Chirality in drug design and development","author":"Reddy","year":"2004"},{"key":"10.1002\/jps.24104_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/128_2006_072","article-title":"From racemates to single enantiomers\u2014Chiral synthetic drugs over the last 20 years","volume":"269","author":"Murakami","year":"2007","journal-title":"Top Curr Chem"},{"key":"10.1002\/jps.24104_bb0030","series-title":"Chiral drugs: Chemistry and biological action","author":"Lin","year":"2011"},{"key":"10.1002\/jps.24104_bb0035","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/anie.201302823","article-title":"Processes to separate enantiomers","volume":"53","author":"Lorenz","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1002\/jps.24104_bb0040","series-title":"Enantiomers, racemates and resolutions","author":"Jacques","year":"1994"},{"key":"10.1002\/jps.24104_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/128_2006_077","article-title":"Preferential crystallization","volume":"269","author":"Coquerel","year":"2007","journal-title":"Top Curr Chem"},{"key":"10.1002\/jps.24104_bb0050","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1039\/c001895c","article-title":"Pitfalls and rewards of preferential crystallization","volume":"12","author":"Levilain","year":"2010","journal-title":"CrystEngComm"},{"key":"10.1002\/jps.24104_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mencom.2012.06.001","article-title":"Crystallization of chiral compounds: Thermodynamical, structural and practical aspects","volume":"22","author":"Bredikhin","year":"2012","journal-title":"Mendeleev Commun"},{"key":"10.1002\/jps.24104_bb0060","series-title":"Analytical profiles of drug substances and excipients, vol 25","first-page":"121","article-title":"Guaifenesin","author":"Shervington","year":"1998"},{"key":"10.1002\/jps.24104_bb0065","series-title":"The Merck index","first-page":"786","author":"O'Neil","year":"2006"},{"key":"10.1002\/jps.24104_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ebch.314","article-title":"Over-the-counter medications for acute cough in children and adults in ambulatory settings","volume":"4","author":"Smith","year":"2009","journal-title":"Evid-Based Child Health"},{"key":"10.1002\/jps.24104_bb0075","first-page":"397","article-title":"Question: Does guaifenesin improve outcomes in patients with cough associated with upper respiratory infection compared with no intervention?","volume":"105","author":"Ramirez","year":"2012","journal-title":"J Okla State Med Assoc"},{"key":"10.1002\/jps.24104_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00408-011-9319-y","article-title":"Therapeutic options for acute cough due to upper respiratory infections in children","volume":"190","author":"Paul","year":"2012","journal-title":"Lung"},{"key":"10.1002\/jps.24104_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11882-009-0015-4","article-title":"Guaifenesin in rhinitis","volume":"9","author":"Storms","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1002\/jps.24104_bb0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.iac.2011.05.008","article-title":"The role of decongestants, cromolyn, guafenesin, saline washes, capsaicin, leukotriene antagonists, and other treatments on rhinitis","volume":"31","author":"Kushnir","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1002\/jps.24104_bb0095","first-page":"114","article-title":"Uricosuric effect of glyceryl guaiacolate","volume":"1","author":"Ramsdell","year":"1974","journal-title":"J Rheumatol"},{"key":"10.1002\/jps.24104_bb0100","first-page":"S212","article-title":"A 1-year, double-blind, placebo-controlled study of guaifenesin","volume":"39","author":"Bennett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1002\/jps.24104_bb0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/jwh.2008.1194","article-title":"Self-reported medication and herb\/supplement use by women with and without fibromyalgia","volume":"18","author":"Shaver","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1002\/jps.24104_bb0110","first-page":"601","article-title":"Combined treatment of idiopathic dysmenorrhoea by acetylsalicylic acid and guaiphenezine","volume":"46","author":"Kraus","year":"1981","journal-title":"Cesk Gynekol"},{"key":"10.1002\/jps.24104_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3122\/jabfm.17.4.240","article-title":"Guaifenesin as a treatment for primary dysmenorrhea","volume":"17","author":"Marsden","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1002\/jps.24104_bb0120","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/jo01363a016","article-title":"Monocarbamates of 1,2-dihydroxy-3-aryloxypropanes","volume":"22","author":"Baizer","year":"1957","journal-title":"J Org Chem"},{"key":"10.1002\/jps.24104_bb0125","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/ja01490a037","article-title":"5-Aryloxymethyl-2-oxazolidinones","volume":"82","author":"Lunsford","year":"1960","journal-title":"J Am Chem Soc"},{"key":"10.1002\/jps.24104_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1070\/MC2003v013n03ABEH001752","article-title":"Systematic search for conglomerates among glycerol aromatic monoethers: Guaifenesin and mephenesin are the cases","volume":"13","author":"Bredikhin","year":"2003","journal-title":"Mendeleev Commun"},{"key":"10.1002\/jps.24104_bb0135","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.tetasy.2006.10.027","article-title":"Solid state properties and effective resolution procedure for guaifenesin, 3-(2-methoxyphenoxy)-1,2-propanediol","volume":"17","author":"Bredikhina","year":"2006","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1002\/jps.24104_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molstruc.2008.11.037","article-title":"Absolute configuration and crystal packing for three chiral drugs prone to spontaneous resolution: Guaifenesin, methocarbamol and mephenesin","volume":"920","author":"Bredikhin","year":"2009","journal-title":"J Mol Struct"},{"key":"10.1002\/jps.24104_bb0145","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.tetasy.2007.05.019","article-title":"Chiral drugs related to guaifenesin: Synthesis and phase properties of methocarbamol and mephenoxalone","volume":"18","author":"Bredikhin","year":"2007","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1002\/jps.24104_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3998\/ark.5550190.0012.a02","article-title":"Synthesis and extraction properties of some lariat ethers derived from the spontaneously resolved guaifenesin, 3-(2-methoxyphenoxy)propane-1,2-diol","volume":"10","author":"Bredikhina","year":"2011","journal-title":"ARKIVOC"},{"key":"10.1002\/jps.24104_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s10847-014-0430-6","article-title":"Lariat ethers in the chiral recognition of amino acid esters: Electrospray ionization mass spectrometry investigation","author":"Bredikhina","year":"2014","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1002\/jps.24104_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1081\/PDT-120024692","article-title":"Solubility of guaifenesin in the presence of common pharmaceutical additives","volume":"8","author":"Mani","year":"2003","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.24104_bb0165","first-page":"372","article-title":"Effect of drug solubility on the in vitro availability rate from suppositories with lipophilic excipients","volume":"55","author":"Realdon","year":"2000","journal-title":"Pharmazie"},{"key":"10.1002\/jps.24104_bb0170","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1002\/jps.22234","article-title":"Enantiomeric 3-chloromandelic acid system: Binary melting point phase diagram, ternary solubility phase diagrams and polymorphism","volume":"99","author":"LeMinh","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24104_bb0175","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/je9001834","article-title":"Solubility and metastable zone width of the methionine enantiomers and their mixtures in water","volume":"54","author":"Polenske","year":"2009","journal-title":"J Chem Eng Data"},{"key":"10.1002\/jps.24104_bb0180","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/cg400296b","article-title":"Crystallization-based resolution process for the 2,3-dibenzoyl-d\/l-tartrate salts of d-\/l-serine benzyl ester","volume":"13","author":"Sistla","year":"2013","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.24104_bb0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/cg400968t","article-title":"Solubility equilibria and crystallographic characterization of the l-threonine\/l-allo-threonine system, Part 1: Solubility equilibria in the threonine diastereomeric system","volume":"14","author":"Binev","year":"2014","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.24104_bb0190","series-title":"The kinetics of industrial crystallization","author":"N\u00fdvlt","year":"1985"},{"key":"10.1002\/jps.24104_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/chir.20067","article-title":"Online monitoring of preferential crystallization of enantiomers","volume":"16","author":"Rodrigo","year":"2004","journal-title":"Chirality"},{"key":"10.1002\/jps.24104_bb0200","series-title":"Crystallization: Basic concepts and industrial applications","first-page":"35","article-title":"Solubility and solution equilibria in crystallization","author":"Lorenz","year":"2013"},{"key":"10.1002\/jps.24104_bb0205","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1039\/C3CS60359H","article-title":"Crystallization of molecular systems from solution: Phase diagrams, supersaturation and other basic concepts","volume":"43","author":"Coquerel","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1002\/jps.24104_bb0210","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1039\/b212062c","article-title":"Solution crystallisation via a submerged liquid-liquid phase boundary: Oiling out","volume":"6","author":"Bonnett","year":"2003","journal-title":"Chem Commun"},{"key":"10.1002\/jps.24104_bb0215","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/cg100605t","article-title":"Phase diagram of a chiral substance exhibiting oiling out in cyclohexane","volume":"10","author":"Codan","year":"2010","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.24104_bb0220","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1021\/cg300890u","article-title":"Phase diagram of a chiral substance exhibiting oiling out. 2. Racemic compound forming ibuprofen in water","volume":"12","author":"Codan","year":"2012","journal-title":"Cryst Growth Des"},{"key":"10.1002\/jps.24104_rf9000","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/cber.19040370313","article-title":"Stereochemische Notizen","volume":"37","author":"Meyerhoffer","year":"1904","journal-title":"Ber Dtsch Chem Ges"},{"key":"10.1002\/jps.24104_rf9005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tetasy.2013.05.017","article-title":"Chiral paraalkyl phenyl ethers of glycerol: Synthesis and testing of chirality driven crystallization, liquid crystal, and gelating properties","volume":"24","author":"Bredikhin","year":"2013","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1002\/jps.24104_bb0230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/op700239a","article-title":"Enantioenrichment by crystallization","volume":"12","author":"Wang","year":"2008","journal-title":"Org Process Res Dev"},{"key":"10.1002\/jps.24104_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1154\/1.1725274","article-title":"Crystal structure of guaifenesin, 3-(2-methoxyphenoxy)-1,2-propanediol","volume":"19","author":"Kaduk","year":"2004","journal-title":"Powder Diffr"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915303865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915303865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T16:11:01Z","timestamp":1649866261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915303865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022354915303865"],"URL":"https:\/\/doi.org\/10.1002\/jps.24104","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}